Data from the KEYNOTE-B61 trial show tumor shrinkage in different types of kidney cancer, including papillary and chromophobe ...

Purple Biotech Ltd. ('Purple Biotech' or 'the Company') (NASDAQ/TASE: PPBT), a clinical-stage company developing ...

Many lung cancers in nonsmokers have no known cause and are discovered only by chance.

A man’s swollen finger and toe turned out to be signs of acrometastasis—a rare, aggressive cancer spread where tumors replace ...

A new test called PAC-MANN is designed to detect signs of pancreatic cancer in blood. It's still in development, but the hope is that it will help catch the deadly cancer early.

Hours after Teddi Mellencamp and her estranged husband Edwin Arroyave’s Los Angeles home was burglarized on July 21, The Real ...

Researchers from the University of Turku and Turku University Hospital, Finland, led by Docent Sami Ventelä and Professor ...

Scientists have uncovered a molecular "on–off" switch that helps lung adenocarcinoma—the most common form of lung cancer—grow ...

Precancerous cells must adapt to and overcome cellular stress and inflammation in order to progress and form malignant tumors.

Doctors may soon have a new tool in the fight against one of the most aggressive and lethal forms of cancer—in the form of an ...

Emerging therapies, including antibody-drug conjugates and biomarker-driven approaches, have the potential to significantly ...

Dispatch Bio is developing a universal immunotherapy by trying to install a synthetic protein — called the “flare” antigen — on every cancer cell in a patient's body.